Related Experiment Videos
Sexual dysfunction in treated breast cancer patients
Summary
Breast cancer treatments significantly impact women's sexual health, leading to increased sexual dysfunction and reduced quality of life. Open communication with partners is more common than with healthcare providers regarding these sensitive issues.
Area of Science:
- Oncology
- Gynecology
- Sexual Health
Background:
- Breast cancer therapies can profoundly affect women's sexual well-being.
- Understanding these impacts is crucial for comprehensive patient care.
Purpose of the Study:
- To investigate the prevalence and nature of sexual dysfunction in breast cancer survivors.
- To assess changes in sexual function before and after treatment.
Main Methods:
- An anonymous questionnaire was administered to 50 sexually active, disease-free breast cancer survivors.
- Participants had undergone surgery at least one year prior and completed CT and/or RT.
- The study included women who had undergone mastectomy (58%) or quadrantectomy (42%) followed by RT.
Main Results:
- 90% of survivors remained sexually active, but 64% reported absent/low sexual desire, and many experienced dyspareunia, frigidity, and lubrication issues.
- Sexual dysfunction worsened in 27% of patients post-treatment, with chemotherapy (26%) and surgery (12%) being primary triggers.
- Half of the women reported changes in their relationship dynamics with their partners.
Conclusions:
- Breast cancer survivors frequently experience sexual dysfunction.
- Patients find it easier to discuss sexual concerns with partners (62%) than with healthcare professionals (15%).